Description

Additional supplementary data from the comprehensive berberine autoimmune hepatitis study, further supporting the connection between gut microbiota modulation and liver inflammation resolution.

More Figures from This Paper

Figure 8

Correlation analysis between gut microbiota changes and hepatic inflammation markers in berberine-treated mice with autoimmune hepatitis.

chart

Figure 11

Supplementary experimental data (panel 11) from the berberine autoimmune hepatitis study, providing additional evidence of gut microbiota modulation and hepatoprotective effects in the concanavalin A mouse model.

chart

Figure 17

Graphical summary of berberine's mechanism of action in alleviating concanavalin A-induced autoimmune hepatitis in mice, highlighting its role in modulating the gut microbiota and restoring intestinal barrier integrity.

diagram

Figure 18

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

chart

Figure 19

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

chart

Figure 20

Extended analysis from the berberine autoimmune hepatitis study, examining molecular pathways or additional biomarkers related to gut-liver axis communication and intestinal barrier function.

chart

Figure 40

Chart

769 × 173px · 122.2 KB

Source Paper

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota.

Hepatology communications (2024)

PMID: 38466881

DOI: 10.1097/HC9.0000000000000381

Cite This Figure

![Figure 40: Additional supplementary data from the comprehensive berberine autoimmune hepatitis study, further supporting the connection between gut microbiota modulation and liver inflammation resolution.](https://pdfs.citedhealth.com/figures/38466881/923.png)

> Source: Hao Yang et al. "Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modu." *Hepatology communications*, 2024. PMID: [38466881](https://pubmed.ncbi.nlm.nih.gov/38466881/)

<figure>
  <img src="https://pdfs.citedhealth.com/figures/38466881/923.png" alt="Additional supplementary data from the comprehensive berberine autoimmune hepatitis study, further supporting the connection between gut microbiota modulation and liver inflammation resolution." />
  <figcaption>Figure 40. Additional supplementary data from the comprehensive berberine autoimmune hepatitis study, further supporting the connection between gut microbiota modulation and liver inflammation resolution.<br>  Source: Hao Yang et al. "Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modu." <em>Hepatology communications</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38466881/">38466881</a></figcaption>
</figure>

Related Evidence

Berberine for Gut Dysbiosis

Grade D · 2 studies